REYATAZ- valmistetta saavilla potilailla on esiintynyt hyperbilirubinemiaa (veren bilirubiinipitoisuuden nousua). ###>Hyperbilirubinaemia (an increase in the level of bilirubin in the blood) has occurred in patients receiving REYATAZ.